2012 SPONSORS
Leadership Council
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Supporting Organizations
Life Sciences Summit 2012 Program*
(2013 Program coming soon)
December 13, 2012
8:30-9:30 am
“Applied Medical Research: An Evolving Paradigm Focused on Patients”
Moderator:
- Julia P. Gregory, EVP and CFO, ContraFect Corporation
Panelists:
- Glenn Batchelder, Founder & Chief Executive Officer of Civitas Therapeutics
- Sohini Chowdhury, Senior Vice President, Research Partnerships, The Michael J. Fox Foundation for Parkinson’s Research
- Howard M. Fillit, MD, Executive Director and Chief Science Officer, Alzheimer’s Drug Discovery Foundation
- Mel Spigelman, MD, President and CEO, TB Alliance
9:30-10:30 am
Moderator:
- Jeffrey M. Bockman, PhD, Vice President Defined Health
Panelists:
- Pamela Carroll, PhD, Appointed VP, Oncology, Janssen/JNJ Innovation Center; Former VP, Oncology Discovery Site Head and Global Head of Pathway Biology, Roche
- Jonathan Lewis, MD, PhD, Chief Executive Officer and Director, ZIOPHARM Oncology
- Yung S. Lie, PhD, Chief Scientific Officer, Damon Runyon Cancer Research Foundation
- Larry Norton, MD, Deputy Physician-in-Chief for Breast Cancer Programs; Medical Director, Evelyn H. Lauder Breast Center, Memorial Sloan-Kettering Cancer Center
9:30-10:30 am
Emerging Company & Innovators Showcase
9:30 am: MedinCell S.A.
9:45 am: Codagenix, Inc.
10:00 am: TargAnox
10:15 am: Gismo Therapeutics, Inc.
10:30-11:30 am
Moderator:
- Jules T. Mitchel, MBA, PhD, President, Target Health Inc.,
Panelists:
- Afia K. Asamoah, Senior Associate, Covington & Burling LLP (Former Special Assistant to the Principal Deputy Commissioner, FDA)
- James Foley, PhD, Partner, AQUA Partners LLC
- Neal Simon, CEO, Azevan Pharmaceuticals, Inc.
10:30-11:30 am
Emerging Company & Innovators Showcase
10:30 am: Alpha1Biologics
10:45 am: TSRL, Inc.
11:00 am: Stony Brook University - Dr. David Komatsu
11:15 am: Stony Brook University - Dr. Agniezska Bialkowska
11:30 am-12:45 pm
"Lunch with Experts"
Summit participant are invited to join a table hosted by a sponsor, moderator and panelist to discuss a specific topic. Hosts and topics will be listed in the ballroom and available at the registration desk onsite.
12:45-1:45 pm
Translational Research Forum - Infectious Diseases:
“Novel Therapies and Vaccines Needed”
Moderator:
- Peter J. Tonge, PhD, Director of Infectious Disease Research, Institute for Chemical Biology and Drug Discovery; Professor, Chemistry, Stony Brook University
Panelists:
- Vincent A. Fischetti, PhD, Professor, Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University
- Steven C. Gilman, PhD, Executive Vice President, Research & Development and Chief Scientific Officer, Cubist Pharmaceuticals, Inc.
- William C. Nierman, PhD, Professor, Director, Infectious Diseases Program, J. Craig Venter Institute
- Matthew A. Wikler, MD, VP New Business Ventures, The Medicines Company
12:45-1:45 pm
Emerging Company & Innovators Showcase
12:45 pm: The Leukemia & Lymphoma Society
1:00 pm: Damon Runyon Cancer Foundation
1:15 pm: Johns Hopkins University - Dr. Marikki Laiho
1:30 pm: Cold Spring Harbor Laboratory - Dr. Lloyd Trotman
1:45-2:45 pm
“Where is the Capital for Early Stage Life Science Companies?”
Moderator:
- William S. Podd, President & Executive Director, Landmark Angels, Inc.; President & CEO, Landmark Capital Corporation
Panelists:
- Morgan Conn, PhD, CLP, Executive Director, Business Development, PTC Therapeutics, Inc.
- Anil Dhundale, PhD, Executive Director, Long Island Technology Incubator and Stony Brook University Business Incubators
- Stephen M. Goodman, Founder, MidAtlantic BioAngels, Partner, Pryor Cashman LLP
- Brian McCarthy, PhD, Biotechnology Consultant
1:45-2:45 pm
Emerging Company & Innovators Showcase
1:45 pm: Quintessence Biosciences, Inc.
2:00 pm: Merck
2:15 pm: Bristol-Myers Squibb
2:45 pm
Coffee Break: Sponsored by Campolo, Middleton, & McCormick, LLP
3:00-4:00 pm
"Collaboration: Working With Industry Means Understanding their Language"
Moderator:
- Carolyn Siegal, Principal, Siegal Consulting
Panelists:
- Mark Day, PhD, Global Lead, Strategic Transactions Group, Bristol-Myers Squibb Company
- Pamela R. Demain PhD, Executive Director, Corporate Licensing, Merck
- Cat Oyler, Senior Director, Emerging Technologies, Johnson & Johnson
3:00-4:00 pm
Emerging Company & Innovators Showcase
3:00 pm: Immunome, Inc.
3:15 pm: Molecular Templates
3:30 pm: Mico Biopharma, Inc.
3:45 pm: Sopharmia
4:00-5:00 pm
“On the Cusp of a New Era In Drug Development”
Moderator:
- Ellen B. Corenswet, Partner, Covington & Burling LLP
Panelists:
- Cláudia Hirawat, President, PTC Therapeutics
- Jonathan S. Leff, Managing Director, Warburg Pincus
- John Ryan, PhD, MD, Executive Vice President, Chief Medical Officer at Kadmon Corporation
- Mervyn J. Turner, PhD, MJTurner Consulting (Merck - Retired)
- Gregory Wiederrecht, PhD, Vice President and Head, External Scientific Affairs, Merck Research Laboratories
5:00-6:30 PM
Partnering Reception
December 14, 2012
7:30 am
8:30-9:30 am
“Raising Money, Attracting Collaborators: Value Creation Starts with an Eye Towards Due Diligence”
Moderator:
- Timothy J. Pelura PhD, Chairman, President & CEO, Immunom, Inc.
Panelists:
- Laurence Blumberg MD, Senior Vice President, Project Management , Kadmon Corporation, LLC
- Kathleen A Denis PhD, CLP, Associate Vice President, Office of Technology Transfer, The Rockefeller University
- Charles S. Ryan, JD, PhD, Senior Vice President & Chief Intellectual Property Counsel, Forest Laboratories, Inc.
- Deborah A. Somerville, Partner, Kenyon & Kenyon LLP
9:30-10:30 am
Translational Research Forum – CNS:
“Major challenges and Emerging Opportunities”
Moderator:
- Andrew Eisen, MD, PhD, Senior Director, Translational Medicine, Acorda Therapeutics
Panelists:
- Timothy Coetzee, PhD, Chief Research Officer, National Multiple Sclerosis Society
- Mark Day, PhD, Global Lead, Strategic Transactions, Bristol-Myers Squibb Company
- Rajesh Ranganathan, PhD, Director, Office of Translational Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health
- Pamela Sklar, MD, PhD, Professor, Genetics & Genomic Sciences, Psychiatry and Neurosciences, Mount Sinai School of Medicine
9:30-10:30 am
Emerging Company & Innovators Showcase
9:30 am: Ezoses Sciences, Inc.
9:45 am: Theragnostic Therapeutics, Inc.
10:00 am: ProteomicFX
10:15 am: SUNY Downstate Medical Center - Dr. Henri Tiedge
10:30-11:30 am
"Academic Drug Discovery: Emerging Models Designed to Advance Academic Discoveries"
Moderator:
- Barbara S. Slusher, PhD, MAS, Director, NeuroTranslational Drug Discovery Program, Brain Science Institute Associate Professor, Neurology and Psychiatry, Johns Hopkins University
Panelists:
- James C. Barrow, PhD, Associate Professor, The Lieber Institute/Johns Hopkins School of Medicine
- Marcie Glicksman, PhD, Co-Director, Laboratory for Drug Discovery in Neurodegeneration, Harvard University
- Joe Mather, MD, Project Director, Neuroscience Innovative Medicines Unit, AstraZeneca
11:30 am-12:45 pm
"Lunch with Experts"
Summit participant are invited to join a table hosted by a sponsor, moderator and panelist to discuss a specific topic. Hosts and topics will be listed in the ballroom and available at the registration desk onsite.
12:45-1:45 pm
Moderator:
- Sudha Kadiyala, PhD, Former Senior Director, Business Development & Strategic Planning, Advanced Technologies & Regenerative Medicine, LLC (ATRM), Johnson & Johnson
Panelists:
- Scott P. Bruder, MD, PhD, Former Chief Science and Technology Officer, Becton, Dickinson and Company
- Daniel Grande, PhD, Director, Orthopaedic Research, Feinstein Institute for Medical Research
- Gail K. Naughton, PhD, Chief Executive Officer & Chairman of the Board, Histogen, Inc.
12:45-1:45 pm
Emerging Company & Innovators Showcase
12:45 pm: Brigham and Women's Hospital and Harvard Medical School - Dr. Marcie Glicksman
1:00 pm: Pfizer Inc
1:15 pm: Enlight Biosciences
1:30 pm: Roche
1:45-2:45 pm
"Insights from Innovative Deals between Academic Scientists, Biotech and Pharma"
Moderator:
- Ruth Plager, President, ZenithBIO
Panelists:
- Zafrira Avnur PhD, Global Head, Academic Innovation, Roche Partnering
- Cammie Edwards PhD, Program Director, UCSF Grand Multiple Myeloma Translational Initiative
- Baruch Harris PhD, Chief Business Officer, Enlight Biosciences
- Ronald Newbold PhD, Vice President, Strategic Research Partnership, External R&D Innovations, World Wide R&D, Pfizer Inc
- Michal Preminger PhD, Executive Director, Harvard Office of Technology Development, Harvard Medical School
1:45-2:45 pm
Emerging Company & Innovators Showcase
1:45 pm: Azevan Pharmaceuticals, Inc.
2:00 pm: Delpor, Inc.
2:15 pm: Genomic Expression
2:30 pm: Curemark, LLC
3:00-4:00 pm
Moderator:
- Eric Elenko PhD, Partner, PureTech Ventures
Panelist:
- Josh Bilenker MD, Partner, Aisling Capital LLC
- Peter Kash, EdD, MBA, President, Riverbank Capital Securities
- Avi Kometz, MD, Partner, Ascent Biomedical Ventures
3:00-4:00 pm
Emerging Company & Innovators Showcase
3:00 pm: The Michael J. Fox Foundation for Parkinson's Research
3:15 pm: New York Stem Cell Foundation
4:00-5:00 pm
Moderator:
- Edward Saltzman, President, Defined Health
Panelists:
- Ron Cohen, MD, President & Chief Executive Officer, Acorda Therapeutics, Inc.
- Nancy J. Kelley, JD, MPP, Founding Executive Director, New York Genome Center
- John McKew, PhD, Chief, Therapeutics Development Branch,National Center for Advancing Translational Sciences, NCATS, NIH
- Mark J. Simon, MBA, Advisor, Torreya Partners
